Euro Heart Survey 2009 Snapshot: Regional variations in presentation and management of patients with AMI in 47 countries

Etienne Puymirat, Alex Battler, John Birkhead, Hector Bueno, Peter Clemmensen, Yves Cottin, Keith Aa Fox, Bulent Gorenek, Christian Hamm, Kurt Huber, Maddalena Lettino, Bertil Lindahl, Christian Müller, Alexander Parkhomenko, Susanna Price, Tom Quinn, Francois Schiele, Maarten Simoons, Gabriel Tatu-Chitoiu, Marco TubaroChristiaan Vrints, Doron Zahger, Uwe Zeymer, Nicolas Danchin, Nicolas Danchin, Alex Battler, Hector Bueno, Keith Fox, Christian Hamm, Bertil Lindahl, Francois Schiele, Maarten Simoons, Michal Tendera, Marco Tubaro, Anselm Gitt

Research output: Contribution to journalArticle

Abstract

Aims: Detailed data on patients admitted for acute myocardial infarction (AMI) on a European-wide basis are lacking. The Euro Heart Survey 2009 Snapshot was designed to assess characteristics, management, and hospital outcomes of AMI patients throughout European Society of Cardiology (ESC) member countries in a contemporary 'real-world' setting, using a methodology designed to improve the representativeness of the survey. Methods: Member countries of the ESC were invited to participate in a 1-week survey of all patients admitted for documented AMI in December 2009. Data on baseline characteristics, type of AMI, management, and complications were recorded using a dedicated electronic form. In addition, we used data collected during the same time period in national registries in Sweden, England, and Wales. Data were centralized at the European Heart House. Results: Overall, 4236 patients (mean age 66±}13 years; 31% women) were included in the study in 47 countries. Sixty per cent of patients had ST-segment elevation myocardial infarction, with 50% having primary percutaneous coronary intervention and 21% fibrinolysis. Aspirin and thienopyridines were used in >90%. Unfractionated and low-molecularweight heparins were the most commonly used anticoagulants. Statins, beta-blockers, and angiotensin-converting enzymeinhibitors were used in >80% of the patients. In-hospital mortality was 6.2%. Regional differences were observed, both in terms of population characteristics, management, and outcomes. Conclusions: In-hospital mortality of patients admitted for AMI in Europe is low. Although regional variations exist in their presentation and management, differences are limited and have only moderate impact on early outcomes.

Original languageEnglish
Pages (from-to)359-370
Number of pages12
JournalEuropean Heart Journal: Acute Cardiovascular Care
Volume2
Issue number4
DOIs
Publication statusPublished - 2013

Fingerprint

Myocardial Infarction
Hospital Mortality
Thienopyridines
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Wales
Angiotensins
Fibrinolysis
Population Characteristics
Percutaneous Coronary Intervention
Surveys and Questionnaires
Cardiology
Sweden
England
Anticoagulants
Aspirin
Registries
Heparin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Euro Heart Survey 2009 Snapshot : Regional variations in presentation and management of patients with AMI in 47 countries. / Puymirat, Etienne; Battler, Alex; Birkhead, John; Bueno, Hector; Clemmensen, Peter; Cottin, Yves; Fox, Keith Aa; Gorenek, Bulent; Hamm, Christian; Huber, Kurt; Lettino, Maddalena; Lindahl, Bertil; Müller, Christian; Parkhomenko, Alexander; Price, Susanna; Quinn, Tom; Schiele, Francois; Simoons, Maarten; Tatu-Chitoiu, Gabriel; Tubaro, Marco; Vrints, Christiaan; Zahger, Doron; Zeymer, Uwe; Danchin, Nicolas; Danchin, Nicolas; Battler, Alex; Bueno, Hector; Fox, Keith; Hamm, Christian; Lindahl, Bertil; Schiele, Francois; Simoons, Maarten; Tendera, Michal; Tubaro, Marco; Gitt, Anselm.

In: European Heart Journal: Acute Cardiovascular Care, Vol. 2, No. 4, 2013, p. 359-370.

Research output: Contribution to journalArticle

Puymirat, E, Battler, A, Birkhead, J, Bueno, H, Clemmensen, P, Cottin, Y, Fox, KA, Gorenek, B, Hamm, C, Huber, K, Lettino, M, Lindahl, B, Müller, C, Parkhomenko, A, Price, S, Quinn, T, Schiele, F, Simoons, M, Tatu-Chitoiu, G, Tubaro, M, Vrints, C, Zahger, D, Zeymer, U, Danchin, N, Danchin, N, Battler, A, Bueno, H, Fox, K, Hamm, C, Lindahl, B, Schiele, F, Simoons, M, Tendera, M, Tubaro, M & Gitt, A 2013, 'Euro Heart Survey 2009 Snapshot: Regional variations in presentation and management of patients with AMI in 47 countries', European Heart Journal: Acute Cardiovascular Care, vol. 2, no. 4, pp. 359-370. https://doi.org/10.1177/2048872613497341
Puymirat, Etienne ; Battler, Alex ; Birkhead, John ; Bueno, Hector ; Clemmensen, Peter ; Cottin, Yves ; Fox, Keith Aa ; Gorenek, Bulent ; Hamm, Christian ; Huber, Kurt ; Lettino, Maddalena ; Lindahl, Bertil ; Müller, Christian ; Parkhomenko, Alexander ; Price, Susanna ; Quinn, Tom ; Schiele, Francois ; Simoons, Maarten ; Tatu-Chitoiu, Gabriel ; Tubaro, Marco ; Vrints, Christiaan ; Zahger, Doron ; Zeymer, Uwe ; Danchin, Nicolas ; Danchin, Nicolas ; Battler, Alex ; Bueno, Hector ; Fox, Keith ; Hamm, Christian ; Lindahl, Bertil ; Schiele, Francois ; Simoons, Maarten ; Tendera, Michal ; Tubaro, Marco ; Gitt, Anselm. / Euro Heart Survey 2009 Snapshot : Regional variations in presentation and management of patients with AMI in 47 countries. In: European Heart Journal: Acute Cardiovascular Care. 2013 ; Vol. 2, No. 4. pp. 359-370.
@article{2af2978d4fe444089b8df28e016687d8,
title = "Euro Heart Survey 2009 Snapshot: Regional variations in presentation and management of patients with AMI in 47 countries",
abstract = "Aims: Detailed data on patients admitted for acute myocardial infarction (AMI) on a European-wide basis are lacking. The Euro Heart Survey 2009 Snapshot was designed to assess characteristics, management, and hospital outcomes of AMI patients throughout European Society of Cardiology (ESC) member countries in a contemporary 'real-world' setting, using a methodology designed to improve the representativeness of the survey. Methods: Member countries of the ESC were invited to participate in a 1-week survey of all patients admitted for documented AMI in December 2009. Data on baseline characteristics, type of AMI, management, and complications were recorded using a dedicated electronic form. In addition, we used data collected during the same time period in national registries in Sweden, England, and Wales. Data were centralized at the European Heart House. Results: Overall, 4236 patients (mean age 66±}13 years; 31{\%} women) were included in the study in 47 countries. Sixty per cent of patients had ST-segment elevation myocardial infarction, with 50{\%} having primary percutaneous coronary intervention and 21{\%} fibrinolysis. Aspirin and thienopyridines were used in >90{\%}. Unfractionated and low-molecularweight heparins were the most commonly used anticoagulants. Statins, beta-blockers, and angiotensin-converting enzymeinhibitors were used in >80{\%} of the patients. In-hospital mortality was 6.2{\%}. Regional differences were observed, both in terms of population characteristics, management, and outcomes. Conclusions: In-hospital mortality of patients admitted for AMI in Europe is low. Although regional variations exist in their presentation and management, differences are limited and have only moderate impact on early outcomes.",
author = "Etienne Puymirat and Alex Battler and John Birkhead and Hector Bueno and Peter Clemmensen and Yves Cottin and Fox, {Keith Aa} and Bulent Gorenek and Christian Hamm and Kurt Huber and Maddalena Lettino and Bertil Lindahl and Christian M{\"u}ller and Alexander Parkhomenko and Susanna Price and Tom Quinn and Francois Schiele and Maarten Simoons and Gabriel Tatu-Chitoiu and Marco Tubaro and Christiaan Vrints and Doron Zahger and Uwe Zeymer and Nicolas Danchin and Nicolas Danchin and Alex Battler and Hector Bueno and Keith Fox and Christian Hamm and Bertil Lindahl and Francois Schiele and Maarten Simoons and Michal Tendera and Marco Tubaro and Anselm Gitt",
year = "2013",
doi = "10.1177/2048872613497341",
language = "English",
volume = "2",
pages = "359--370",
journal = "European Heart Journal: Acute Cardiovascular Care",
issn = "2048-8726",
publisher = "Sage Publications",
number = "4",

}

TY - JOUR

T1 - Euro Heart Survey 2009 Snapshot

T2 - Regional variations in presentation and management of patients with AMI in 47 countries

AU - Puymirat, Etienne

AU - Battler, Alex

AU - Birkhead, John

AU - Bueno, Hector

AU - Clemmensen, Peter

AU - Cottin, Yves

AU - Fox, Keith Aa

AU - Gorenek, Bulent

AU - Hamm, Christian

AU - Huber, Kurt

AU - Lettino, Maddalena

AU - Lindahl, Bertil

AU - Müller, Christian

AU - Parkhomenko, Alexander

AU - Price, Susanna

AU - Quinn, Tom

AU - Schiele, Francois

AU - Simoons, Maarten

AU - Tatu-Chitoiu, Gabriel

AU - Tubaro, Marco

AU - Vrints, Christiaan

AU - Zahger, Doron

AU - Zeymer, Uwe

AU - Danchin, Nicolas

AU - Danchin, Nicolas

AU - Battler, Alex

AU - Bueno, Hector

AU - Fox, Keith

AU - Hamm, Christian

AU - Lindahl, Bertil

AU - Schiele, Francois

AU - Simoons, Maarten

AU - Tendera, Michal

AU - Tubaro, Marco

AU - Gitt, Anselm

PY - 2013

Y1 - 2013

N2 - Aims: Detailed data on patients admitted for acute myocardial infarction (AMI) on a European-wide basis are lacking. The Euro Heart Survey 2009 Snapshot was designed to assess characteristics, management, and hospital outcomes of AMI patients throughout European Society of Cardiology (ESC) member countries in a contemporary 'real-world' setting, using a methodology designed to improve the representativeness of the survey. Methods: Member countries of the ESC were invited to participate in a 1-week survey of all patients admitted for documented AMI in December 2009. Data on baseline characteristics, type of AMI, management, and complications were recorded using a dedicated electronic form. In addition, we used data collected during the same time period in national registries in Sweden, England, and Wales. Data were centralized at the European Heart House. Results: Overall, 4236 patients (mean age 66±}13 years; 31% women) were included in the study in 47 countries. Sixty per cent of patients had ST-segment elevation myocardial infarction, with 50% having primary percutaneous coronary intervention and 21% fibrinolysis. Aspirin and thienopyridines were used in >90%. Unfractionated and low-molecularweight heparins were the most commonly used anticoagulants. Statins, beta-blockers, and angiotensin-converting enzymeinhibitors were used in >80% of the patients. In-hospital mortality was 6.2%. Regional differences were observed, both in terms of population characteristics, management, and outcomes. Conclusions: In-hospital mortality of patients admitted for AMI in Europe is low. Although regional variations exist in their presentation and management, differences are limited and have only moderate impact on early outcomes.

AB - Aims: Detailed data on patients admitted for acute myocardial infarction (AMI) on a European-wide basis are lacking. The Euro Heart Survey 2009 Snapshot was designed to assess characteristics, management, and hospital outcomes of AMI patients throughout European Society of Cardiology (ESC) member countries in a contemporary 'real-world' setting, using a methodology designed to improve the representativeness of the survey. Methods: Member countries of the ESC were invited to participate in a 1-week survey of all patients admitted for documented AMI in December 2009. Data on baseline characteristics, type of AMI, management, and complications were recorded using a dedicated electronic form. In addition, we used data collected during the same time period in national registries in Sweden, England, and Wales. Data were centralized at the European Heart House. Results: Overall, 4236 patients (mean age 66±}13 years; 31% women) were included in the study in 47 countries. Sixty per cent of patients had ST-segment elevation myocardial infarction, with 50% having primary percutaneous coronary intervention and 21% fibrinolysis. Aspirin and thienopyridines were used in >90%. Unfractionated and low-molecularweight heparins were the most commonly used anticoagulants. Statins, beta-blockers, and angiotensin-converting enzymeinhibitors were used in >80% of the patients. In-hospital mortality was 6.2%. Regional differences were observed, both in terms of population characteristics, management, and outcomes. Conclusions: In-hospital mortality of patients admitted for AMI in Europe is low. Although regional variations exist in their presentation and management, differences are limited and have only moderate impact on early outcomes.

UR - http://www.scopus.com/inward/record.url?scp=84902206112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902206112&partnerID=8YFLogxK

U2 - 10.1177/2048872613497341

DO - 10.1177/2048872613497341

M3 - Article

C2 - 24338295

AN - SCOPUS:84902206112

VL - 2

SP - 359

EP - 370

JO - European Heart Journal: Acute Cardiovascular Care

JF - European Heart Journal: Acute Cardiovascular Care

SN - 2048-8726

IS - 4

ER -